Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 666 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Phase 1 Study Of XL309 (ISM3091) Alone And In Combination In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Colorectal Cancer Screening/Microbiome Collection

    Jacksonville, FL

  3. A Study To Evaluate Safety, PK, PD And Efficacy Of AZD5492, A T Cell-engaging Antibody Targeting CD20 In Subjects With R/R B-Cell Malignancies.

    Rochester, MN

  4. A Study Of SPX-303, A Bispecific Antibody Targeting LILRB2 And PD-L1 In Patients With Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Testing The Addition Of MEDI4736 (Durvalumab) To Chemotherapy Before Surgery For Patients With High-Grade Upper Urinary Tract Cancer

    Jacksonville, FL, Rochester, MN

  7. A First-in-Human Study Of MEN2312 In Adults With Advanced Breast Cancer

    Rochester, MN

  8. Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)

    Jacksonville, FL

  9. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. A Study To Investigate The Safety, Tolerability, Pharmacokinetics, And Anti-tumor Activity Of CBI-1214 T Cell Engager In Participants With Advanced Or Metastatic MSS/MSI-L Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer